Yongquan Shi
Clinical trials sponsored by Yongquan Shi, explained in plain language.
-
Old drug thalidomide tested for new use: healing radiation-damaged intestines
Disease control Recruiting nowThis study is testing whether thalidomide combined with glutamine can help control bleeding and other symptoms in people who developed intestinal damage after radiation therapy for cancer. Researchers will enroll 150 adults who experience frequent bloody bowel movements due to th…
Phase: PHASE2 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Probiotic boost tested to finally beat stubborn stomach bug
Disease control Recruiting nowThis study is for people whose previous treatments failed to clear an H. pylori stomach infection. It tests whether adding a specific probiotic (Saccharomyces boulardii) to a standard 14-day antibiotic regimen makes the treatment more effective and safer. About 1,248 adults who h…
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New trial aims to turn back the clock on Pre-Cancerous stomach change
Disease control Recruiting nowThis study is testing if a medication called ursodeoxycholic acid can reverse a specific change in the stomach lining called intestinal metaplasia, which can increase cancer risk. Researchers will compare the drug to a placebo in about 196 adults who do not have an H. pylori infe…
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC